Yamashita Hiroyuki, Ueda Yo, Ozaki Takashi, Tsuchiya Haruka, Takahashi Yuko, Kaneko Hiroshi, Kano Toshikazu, Mimori Akio
Division of Rheumatic Diseases, National Center for Global Health and Medicine , Shinjuku-ku, Tokyo , Japan.
Mod Rheumatol. 2014 May;24(3):492-8. doi: 10.3109/14397595.2013.843762. Epub 2013 Nov 5.
To evaluate the possible correlation of malignant neoplasms and paraneoplastic rheumatologic syndromes.
We studied a series of 10 patients with paraneoplastic rheumatological syndromes collected from our Division of Rheumatic Disease between 2006 and 2012.
Our series consisted of four males and six females, with a mean age of 65.5 years (range, 57-78 years). Of the 10 patients recruited, six had hematological malignancies and four had solid cancers. Malignancies were diagnosed after rheumatic symptoms were reported in all patients. Compared to solid tumors, hemopathy was diagnosed at a later time point (16.2 vs. 7.3 months). Extra-articular symptoms were associated with rheumatologic musculoskeletal manifestations in 100% of the patients. Polyarthritis was the main rheumatologic musculoskeletal manifestation (50% of the patients). The other manifestations were oligopolyarthritis and polymyalgia rheumatic-like symptoms (20% of the patients). Symmetric arthritis was present in 60% of the patients, and the remaining patients developed asymmetric arthritis. Musculoskeletal manifestations completely regressed in 66.7% of the patients after cancer therapy. When tumor relapse was observed, rheumatic symptoms did not recur in any of our patients (100%).
Rheumatic disorders with atypical clinical presentation in older patients, poor response to usual treatment and systemic features such as weight loss and clinical findings compatible with well-recognized paraneoplastic syndromes should alert clinicians to the possible coexistence of an occult malignancy. Especially in cases of paraneoplastic rheumatic/musculoskeletal manifestations associated with hemopathy, the primary disease is unlikely to have manifested yet, making the diagnosis difficult. Thus, caution is required.
评估恶性肿瘤与副肿瘤性风湿综合征之间可能存在的相关性。
我们研究了2006年至2012年间从我们风湿病科收集的一系列10例副肿瘤性风湿综合征患者。
我们的研究系列包括4名男性和6名女性,平均年龄为65.5岁(范围57 - 78岁)。在招募的10名患者中,6例患有血液系统恶性肿瘤,4例患有实体癌。所有患者在出现风湿症状后被诊断出患有恶性肿瘤。与实体瘤相比,血液系统疾病在更晚的时间点被诊断出来(16.2个月对7.3个月)。100%的患者关节外症状与风湿性肌肉骨骼表现相关。多关节炎是主要的风湿性肌肉骨骼表现(50%的患者)。其他表现为少关节炎和风湿性多肌痛样症状(20%的患者)。60%的患者出现对称性关节炎,其余患者出现不对称性关节炎。66.7%的患者在癌症治疗后肌肉骨骼表现完全消退。当观察到肿瘤复发时,我们的患者中没有任何一例风湿症状复发(100%)。
老年患者出现非典型临床表现、对常规治疗反应不佳以及体重减轻等全身特征和与公认的副肿瘤综合征相符的临床表现的风湿性疾病,应提醒临床医生注意可能存在隐匿性恶性肿瘤。特别是在与血液系统疾病相关的副肿瘤性风湿/肌肉骨骼表现的病例中,原发性疾病可能尚未表现出来,这使得诊断困难。因此,需要谨慎对待。